Cleared Traditional

K172062 - AllergiEnd ST-9 Multiple Skin Test Appl...

K172062 is the FDA 510(k) clearance for AllergiEnd ST-9 Multiple Skin Test Appl... by Medscience Science Research Group, Inc.. It is a Class 2 General Hospital device (product code SCL) cleared through the Traditional 510(k) pathway after a 241-day FDA review.

K172062 · Medscience Science Research Group, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2018
Decision
241d
Days
Class 2
Risk

K172062 is an FDA 510(k) clearance for the AllergiEnd ST-9 Multiple Skin Test Applicator, AllergiEnd ST-9 Multiple Well .... Classified as Allergen And Vaccine Delivery Needles (product code SCL), Class II - Special Controls.

Submitted by Medscience Science Research Group, Inc. (Delray Beach, US). The FDA issued a Cleared decision on March 5, 2018 after a review of 241 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medscience Science Research Group, Inc. devices

Submission Details

510(k) Number K172062 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2017
Decision Date March 05, 2018
Days to Decision 241 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d slower than avg
Panel avg: 129d · This submission: 241d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code SCL Allergen And Vaccine Delivery Needles
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
Definition An Allergen Delivery Needle Is A Device Intended To Percutaneously Deliver Diagnostic Allergenic Extracts For Use In Allergy Skin Tests Also Referred To As Skin Prick Tests Or Intradermal Allergy Tests.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Emergo Global Consulting, LLC
Audrey Swearingen

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - SCL Allergen And Vaccine Delivery Needles

Devices cleared under the same product code (SCL) and FDA review panel - the closest regulatory comparables to K172062.
Medblue Skin Prick Test Applicator (AS103, AS108, AS109, AS110, AS111, AS113, AS132, AS134, AS146, AS148, AS160, AS162, AS170, AS172)
K250983 · Asistan Medikal · Jan 2026
Bifurcated Needle
K222385 · Anhui Tiankang Medical Technology Co., Ltd. · Dec 2022
Oryum and Ovem Epidermal Deri Prick Test Applicator
K182582 · Allergy & Applicator Depot, LLC · Apr 2019
BD ECLIPSE BIFURCATED NEEDLE
K032528 · Becton, Dickinson & CO · Sep 2003
QUINTEST
K953939 · Bayer Corp. · Nov 1995